The transition away from conventional proton pump inhibitors (PPIs) toward next-generation acid suppression chemistry is propelling demand for high-purity active pharmaceutical ingredients (APIs). Detailed analysis within the Vonoprazan Fumarate Api Market report highlights how vonoprazan fumarate—a potassium-competitive acid blocker (P-CAB)—delivers rapid, potent, and reversible...